> For the complete documentation index, see [llms.txt](https://www.thiamine.wiki/llms.txt). Markdown versions of documentation pages are available by appending `.md` to page URLs; this page is available as [Markdown](https://www.thiamine.wiki/biochemistry/ketoacid-metabolism.md).

# ketoacid metabolism

{% hint style="info" %}
**Section:** Complete Biochemistry → Coenzyme Pathways\
**Reading level:** Technical, with a plain-language summary\
**Last reviewed:** October 2026 · **Evidence status:** Well established (pathways); moderate (diagnostic patterns in thiamine deficiency)
{% endhint %}

## Summary

**α-Keto acids** (also called 2-oxo acids) are small molecules with a carbonyl group next to a carboxylic acid. They sit at the crossroads of carbohydrate, amino acid and energy metabolism. Each has three possible fates:

1. **Reversible transamination** to an amino acid (requires vitamin B6).
2. **Reduction** (for example, pyruvate to lactate).
3. **Irreversible oxidative decarboxylation** to an acyl-CoA, which **requires thiamine pyrophosphate (TPP)**.

Thiamine therefore controls the committed, energy-yielding route for several key keto acids. When TPP is short, keto acids back up and are diverted into the other fates, producing characteristic metabolic changes such as raised lactate.

## The α-keto acids that depend on thiamine

| Keto acid                            | Main sources                            | TPP-dependent enzyme                              | Product             | Downstream fate                                                  |
| ------------------------------------ | --------------------------------------- | ------------------------------------------------- | ------------------- | ---------------------------------------------------------------- |
| **Pyruvate**                         | Glycolysis, lactate, alanine            | Pyruvate dehydrogenase                            | Acetyl-CoA          | Krebs cycle, fatty acid and cholesterol synthesis, acetylcholine |
| **2-Oxoglutarate (α-ketoglutarate)** | Krebs cycle, glutamate                  | 2-Oxoglutarate dehydrogenase                      | Succinyl-CoA        | Krebs cycle, heme synthesis                                      |
| **α-Ketoisocaproate (KIC)**          | Leucine                                 | Branched-chain α-ketoacid dehydrogenase           | Isovaleryl-CoA      | Acetoacetate + acetyl-CoA (ketogenic)                            |
| **α-Keto-β-methylvalerate (KMV)**    | Isoleucine                              | Branched-chain α-ketoacid dehydrogenase           | α-Methylbutyryl-CoA | Acetyl-CoA + propionyl-CoA                                       |
| **α-Ketoisovalerate (KIV)**          | Valine                                  | Branched-chain α-ketoacid dehydrogenase           | Isobutyryl-CoA      | Propionyl-CoA → succinyl-CoA (glucogenic)                        |
| **2-Oxoadipate**                     | Lysine, hydroxylysine, tryptophan       | 2-Oxoadipate dehydrogenase (DHTKD1)               | Glutaryl-CoA        | Acetyl-CoA                                                       |
| **α-Ketobutyrate**                   | Threonine; methionine via cystathionine | Branched-chain α-ketoacid dehydrogenase (and PDH) | Propionyl-CoA       | Succinyl-CoA                                                     |

Not every keto acid depends on thiamine. **Oxaloacetate**, for example, is handled by transamination and by PEP carboxykinase. Glyoxylate is handled by transamination and other routes.

## Competing fates

| Fate                              | Enzymes                                              | Cofactor                     | Reversible? | What happens in TPP deficiency                        |
| --------------------------------- | ---------------------------------------------------- | ---------------------------- | ----------- | ----------------------------------------------------- |
| **Oxidative decarboxylation**     | 2-Oxo acid dehydrogenase complexes                   | TPP, lipoate, CoA, FAD, NAD⁺ | No          | Reduced                                               |
| **Transamination**                | ALT, AST, branched-chain aminotransferases (BCAT1/2) | Pyridoxal phosphate (B6)     | Yes         | Increased flux to alanine, glutamate and BCAAs        |
| **Reduction**                     | Lactate dehydrogenase; hydroxy acid dehydrogenases   | NADH                         | Yes         | Increased lactate and 2-hydroxy acids                 |
| **Carboxylation** (pyruvate only) | Pyruvate carboxylase                                 | Biotin                       | No          | Pyruvate diverted to oxaloacetate and gluconeogenesis |

## Pyruvate and lactate

Pyruvate is the end product of glycolysis. Under aerobic conditions, most is oxidized by pyruvate dehydrogenase. When PDH is impaired, pyruvate accumulates and is converted to lactate, producing **type B lactic acidosis** (that is, not caused by poor oxygen delivery).

### The lactate/pyruvate ratio

| Pattern                                     | Typical lactate/pyruvate ratio   | Suggests                                                       |
| ------------------------------------------- | -------------------------------- | -------------------------------------------------------------- |
| Raised lactate **and** raised pyruvate      | Normal or low (roughly under 20) | Block at PDH, including PDH deficiency and thiamine deficiency |
| Raised lactate with relatively low pyruvate | High (above about 25)            | Respiratory chain dysfunction or hypoxia (high NADH/NAD⁺)      |

Interpretation is complicated by sample handling, critical illness and mixed causes. The pattern is a clue, not a diagnosis.

In critically ill patients with septic shock, low thiamine levels are common, and lactate has been observed to correlate inversely with thiamine in some studies. Trials of thiamine in sepsis have given mixed results (see [Why Thiamine Matters](broken://pages/91b62a2d384ec2b3bc2296fbdbc21c54af4da622)).

### A historical note

In the 1930s, **Rudolph Peters** showed that brain tissue from thiamine-deficient pigeons accumulated pyruvate and could not oxidize it normally. He called this the **"biochemical lesion"**, one of the first demonstrations that a vitamin deficiency causes disease through a specific metabolic block. Blood pyruvate measurement was later used, with limited specificity, as an early test of thiamine status.

## α-Ketoglutarate (2-oxoglutarate)

α-Ketoglutarate is both a **Krebs cycle intermediate** and the keto acid of **glutamate**. When 2-oxoglutarate dehydrogenase is impaired:

* α-ketoglutarate accumulates and can be **transaminated to glutamate**;
* Krebs cycle flux and NADH production fall;
* raised glutamate has been proposed to contribute to excitotoxic damage in Wernicke encephalopathy (supported mainly by animal models).

α-Ketoglutarate is also a co-substrate for **2-oxoglutarate-dependent dioxygenases**, enzymes involved in DNA and histone demethylation and in oxygen sensing (HIF prolyl hydroxylases). Whether changes in α-ketoglutarate during thiamine deficiency affect these processes is an open research question.

## Branched-chain amino acid catabolism

| Step                                                               | Enzyme                                   | Tissue emphasis                            | Cofactor                                             |
| ------------------------------------------------------------------ | ---------------------------------------- | ------------------------------------------ | ---------------------------------------------------- |
| 1. Transamination of leucine, isoleucine, valine to keto acids     | BCAT2 (mitochondrial), BCAT1 (cytosolic) | Skeletal muscle                            | B6                                                   |
| 2. Oxidative decarboxylation of keto acids                         | BCKDH complex                            | Liver (high), muscle, kidney, heart, brain | **TPP**, lipoate, CoA, FAD, NAD⁺                     |
| 3. Further oxidation to acetyl-CoA, acetoacetate and propionyl-CoA | Multiple enzymes                         | Various                                    | Various (including biotin and B12 for propionyl-CoA) |

BCKDH is regulated by phosphorylation: **BCKDH kinase (BCKDK)** inactivates it and **PPM1K** activates it.

### Maple syrup urine disease (MSUD)

Inherited BCKDH deficiency causes accumulation of branched-chain amino acids and keto acids, the characteristic marker **alloisoleucine**, and a maple-syrup odour. Severe forms cause life-threatening encephalopathy in newborns. A minority of variant forms partially respond to thiamine (see [TPP-Dependent Enzymes](broken://pages/48b61d9218e12eeb5f0e1876c67ae5de17b143ff)).

### BCAAs and metabolic disease

Raised circulating BCAAs and branched-chain keto acids are associated with insulin resistance and type 2 diabetes, and BCKDH activity is reduced in some models of obesity. This is an active research area. Any role for thiamine status in these associations is **speculative** and has not been tested in controlled human studies.

## Keto acids versus ketone bodies

These terms are often confused.

|                          | α-Keto acids                                         | Ketone bodies                                                                       |
| ------------------------ | ---------------------------------------------------- | ----------------------------------------------------------------------------------- |
| **Examples**             | Pyruvate, α-ketoglutarate, branched-chain keto acids | Acetoacetate, β-hydroxybutyrate, acetone                                            |
| **Chemistry**            | Carbonyl next to the carboxyl (α position)           | Acetoacetate is a β-keto acid; β-hydroxybutyrate is not a keto acid                 |
| **Directly need TPP?**   | Yes, for oxidative decarboxylation                   | No: oxidized via succinyl-CoA:3-ketoacid CoA transferase and thiolase to acetyl-CoA |
| **Need TPP downstream?** | —                                                    | Yes: acetyl-CoA enters the Krebs cycle, which needs 2-oxoglutarate dehydrogenase    |

Two consequences follow:

* **Ketogenic diets** are used to treat PDH deficiency because ketone bodies supply acetyl-CoA without going through PDH.
* Lower carbohydrate intake may reduce flux through PDH, and therefore possibly thiamine use. However, the Krebs cycle still requires TPP. Whether low-carbohydrate diets meaningfully lower thiamine requirements has **not been established**.

## Metabolic signatures of thiamine deficiency

Urine organic acid and blood analyses in thiamine deficiency may show:

| Marker                                                          | Reflects                    |
| --------------------------------------------------------------- | --------------------------- |
| Raised blood lactate and pyruvate                               | PDH impairment              |
| Raised α-ketoglutarate in urine                                 | OGDH impairment             |
| Raised branched-chain keto acids or their 2-hydroxy derivatives | BCKDH impairment            |
| Raised alanine and glutamate                                    | Diversion by transamination |

These changes are **non-specific**. They also occur in inherited enzyme defects, mitochondrial disease, critical illness and other conditions. They are not substitutes for direct thiamine measurement and clinical assessment (see [Testing Limitations](broken://pages/1413ea1d53e19f9a39d0758ef8331327b1cf2bc4)).

## Evidence quality

| Claim type                                             | Strength                                                                     |
| ------------------------------------------------------ | ---------------------------------------------------------------------------- |
| Keto acid pathways and enzymes                         | **Strong**                                                                   |
| Lactate/pyruvate ratio patterns                        | **Moderate**: widely used in metabolic medicine, with recognized limitations |
| Organic acid signatures of thiamine deficiency         | **Moderate to limited**: case reports and small series                       |
| Influence of diet composition on thiamine requirements | **Limited**                                                                  |
| Thiamine and BCAA-related metabolic disease            | **Speculative**                                                              |

## Open questions

* Whether thiamine requirements scale with carbohydrate intake in a predictable, measurable way.
* Whether α-ketoglutarate accumulation in thiamine deficiency affects epigenetic or oxygen-sensing enzymes.
* Whether organic acid profiling could help identify early or marginal deficiency.

## Related pages

* [Oxidative Decarboxylation](broken://pages/aff327c1d64ad1abd2c61500f4b7cb2993cb7830)
* [TPP-Dependent Enzymes](broken://pages/48b61d9218e12eeb5f0e1876c67ae5de17b143ff)
* [Pentose Phosphate Pathway](broken://pages/63cc26a45948f6188857defdc77e37bfecabe456)
* [Why Thiamine Matters](broken://pages/91b62a2d384ec2b3bc2296fbdbc21c54af4da622)

## References

1. Peters RA. The biochemical lesion in vitamin B1 deficiency. *Lancet*. 1936;227:1161–1165.
2. Patel MS, Nemeria NS, Furey W, Jordan F. The pyruvate dehydrogenase complexes: structure-based function and regulation. *Journal of Biological Chemistry*. 2014;289(24):16615–16623.
3. Chuang DT, Chuang JL, Wynn RM. Lessons from genetic disorders of branched-chain amino acid metabolism. *Journal of Nutrition*. 2006;136(1 Suppl):243S–249S.
4. Neinast M, Murashige D, Arany Z. Branched chain amino acids. *Annual Review of Physiology*. 2019;81:139–164.
5. Robinson BH. Lactic acidemia and mitochondrial disease. *Molecular Genetics and Metabolism*. 2006;89(1–2):3–13.
6. Donnino MW, et al. Thiamine deficiency in critically ill patients with sepsis. *Journal of Critical Care*. 2010;25(4):576–581.
7. Danhauser K, et al. *DHTKD1* mutations cause 2-aminoadipic and 2-oxoadipic aciduria. *American Journal of Human Genetics*. 2012;91(6):1082–1087.
8. Hazell AS, Butterworth RF. Update of cell damage mechanisms in thiamine deficiency: focus on oxidative stress, excitotoxicity and inflammation. *Alcohol and Alcoholism*. 2009;44(2):141–147.

{% hint style="info" %}
**Editorial note:** This page describes mechanisms and published evidence. It is not medical advice and does not recommend doses. Suggest corrections or new sources via the feedback link.
{% endhint %}
